Home Featured

Featured

Here’s What’s Going On With Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) and Akari Therapeutics (NASDAQ:AKTX)

- April 10, 2017

Market Morning: Boeing Tragedy, Inflation Payrolls & Unemployment, Walmart Challenges Amazon Go

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Pfizer Inc. (NYSE:PFE) Backed ArQule, Inc. (NASDAQ:ARQL) Just Gave Investors Something to Smile About

Emerald Health Fulfills Yukon Purchase Order, Alberta Supply Agreement

Cannabis Sector Weekly Roundup

Here’s Our Take On Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s Ingrezza

- October 12, 2016 0

Short Squeezes On the Left, Covid Stocks on the Right, 4...

ME Staff - January 29, 2021 0

Biotech Mergers: Impax Laboratories, Inc. (NASDAQ:IPXL) and Neothetics, Inc. (NASDAQ:NEOT)

- October 18, 2017 0

Catabasis Pharmaceuticals Inc (NASDAQ:CATB): What’s Next?

- February 1, 2017 0

The Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Looks Like An Opportunity

- September 25, 2017 0

Aethlon Medical Inc. (NASDAQ:AEMD) Readies CTE Blood Diagnostic Trial As Super...

David Rich - January 25, 2017 0

Bitcoin & All Major Crypto Currencies Crash – Crypto Currency Daily...

ME Staff - June 22, 2018 0

High Risk, High Reward on Telesta’s Panel Review

ME Staff - November 13, 2015 1

Biotechnology Movers: Karyopharm And Synergy

- January 26, 2018 0

A Look At Puma Biotechnology Inc (NYSE:PBYI)’s Breast Cancer Candidate

- July 25, 2016 0

12 3...144 Page 1 of 144

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.